PubMed:27172902 / 0-254
Annnotations
LitCoin-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-166 | Sentence | denotes | Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity. |
LitCoin-entities
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| 11281 | 0-9 | ChemicalEntity | denotes | Cisplatin | MESH:D002945 |
| 11282 | 61-64 | GeneOrGeneProduct | denotes | TLR | NCBIGene:13982 |
| 11283 | 105-110 | GeneOrGeneProduct | denotes | IL-10 | NCBIGene:16153 |
| 11284 | 203-212 | ChemicalEntity | denotes | cisplatin | MESH:D002945 |
| 11285 | 214-242 | ChemicalEntity | denotes | cis-diamminedichloroplatinum | MESH:D002945 |
| 11286 | 249-253 | ChemicalEntity | denotes | CDDP | MESH:D002945 |
LitCoin-GeneOrGeneProduct-v0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-9 | GeneOrGeneProduct | denotes | Cisplatin |
| T2 | 10-17 | GeneOrGeneProduct | denotes | induces |
| T3 | 40-45 | GeneOrGeneProduct | denotes | cells |
| T4 | 91-101 | GeneOrGeneProduct | denotes | production |
| T5 | 105-110 | GeneOrGeneProduct | denotes | IL-10 |
| T6 | 139-142 | GeneOrGeneProduct | denotes | Tr1 |
| T7 | 152-156 | GeneOrGeneProduct | denotes | cell |
| T8 | 157-165 | GeneOrGeneProduct | denotes | immunity |
| T9 | 176-180 | GeneOrGeneProduct | denotes | many |
| T10 | 203-212 | GeneOrGeneProduct | denotes | cisplatin |
| T11 | 244-246 | GeneOrGeneProduct | denotes | II |
LitCoin-GeneOrGeneProduct-v2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-9 | GeneOrGeneProduct | denotes | Cisplatin |
| T2 | 105-110 | GeneOrGeneProduct | denotes | IL-10 |
| T3 | 152-156 | GeneOrGeneProduct | denotes | cell |
| T4 | 157-165 | GeneOrGeneProduct | denotes | immunity |
| T5 | 203-212 | GeneOrGeneProduct | denotes | cisplatin |
LitCoin-GeneOrGeneProduct-v3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 61-64 | GeneOrGeneProduct | denotes | TLR |
| T2 | 105-110 | GeneOrGeneProduct | denotes | IL-10 |
LitCoin-Chemical-MeSH-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T1 | 0-9 | ChemicalEntity | denotes | Cisplatin | http://purl.obolibrary.org/obo/CHEBI_27899 |
| T2 | 203-212 | ChemicalEntity | denotes | cisplatin | D002945|http://purl.obolibrary.org/obo/CHEBI_27899 |
| T4 | 214-242 | ChemicalEntity | denotes | cis-diamminedichloroplatinum | http://purl.obolibrary.org/obo/CHEBI_27899 |
| T5 | 249-253 | ChemicalEntity | denotes | CDDP | http://purl.obolibrary.org/obo/CHEBI_27899 |
LitCoin-NCBITaxon-2
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 214-217 | OrganismTaxon | denotes | cis |
LitCoin-training-merged
| Id | Subject | Object | Predicate | Lexical cue | ID: |
|---|---|---|---|---|---|
| T5 | 249-253 | ChemicalEntity | denotes | CDDP | http://purl.obolibrary.org/obo/CHEBI_27899 |
| T4 | 214-242 | ChemicalEntity | denotes | cis-diamminedichloroplatinum | http://purl.obolibrary.org/obo/CHEBI_27899 |
| T2 | 203-212 | ChemicalEntity | denotes | cisplatin | http://purl.obolibrary.org/obo/CHEBI_27899|D002945 |
| T1 | 0-9 | ChemicalEntity | denotes | Cisplatin | http://purl.obolibrary.org/obo/CHEBI_27899 |
| T31928 | 105-110 | GeneOrGeneProduct | denotes | IL-10 | |
| T64036 | 61-64 | GeneOrGeneProduct | denotes | TLR | |
| T44809 | 214-217 | OrganismTaxon | denotes | cis |
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-166 | Sentence | denotes | Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity. |
| T1 | 0-166 | Sentence | denotes | Cisplatin induces tolerogenic dendritic cells in response to TLR agonists via the abundant production of IL-10, thereby promoting Th2- and Tr1-biased T-cell immunity. |